Functional analysis on the 5′-flanking region of human FXR gene in HepG2 cells

Gene

Volumn 396, Issue 2, 2007, Pages 358-368

  Lou, Guiyu ^a   Li, Yuping ^a   Chen, Bin ^a   Chen, Min ^a   Chen, Jian ^a   Liao, Rongxia ^a   Zhang, Yan ^a   Wang, Yuangzhon ^a   Zhou, Dujin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Farnesoid X receptor; Hepatic nuclear factor 1 ; Promoter analysis

Indexed keywords

FARNESOID X RECEPTOR; HEPATIC NUCLEAR FACTOR 1ALPHA; NUCLEOTIDE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL STRAIN HEPG2; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA FLANKING REGION; EXPRESSION VECTOR; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENE DELETION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; REGULATORY MECHANISM; SEQUENCE ANALYSIS; UPREGULATION;

BASE SEQUENCE; BINDING SITES; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; EXONS; GENE DELETION; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR SEQUENCE DATA; POINT MUTATION; PROMOTER REGIONS (GENETICS); RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 34250687888     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2007.04.011     Document Type: Article

References (30)

1. Bach I., Mattei M.G., Cereghini S., and Yaniv M. Two members of an HNF1 homeoprotein family are expressed in mouse liver. Nucleic Acids Res. 19 (1991) C3553-C3559
2. Baumhueter S., et al. HNF-1 shares three sequence motifs with the POU domain proteins and is identical to LF-B1 and APF. Genes Dev. 4 (1990) C372-C379
3. Bishop-Bailey D., Walsh D.T., and Warner T.D. Expression and activation of the farnesoid X receptor in the vasculature. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) C3668-C3673
4. Boj S., Parrizas M., Maestro M., and Ferrer J. A transcription factor regulatory circuit in differentiated pancreatic cells. Proc. Natl. Acad Sci. U. S. A. 98 (2001) C14481-C14486
5. Cariou B., et al. Transient impairment of the adaptive response to fasting in FXR-deficient mice. FEBS Lett. 579 (2005) C4076-C4080
6. Claudel T., et al. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element. J. Clin. Invest. 109 (2002) C961-C971 10.1172/JCI200214505
7. Claudel T., et al. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. Gastroenterology. 125 (2003) C544-C555
8. Claudel T., Staels B., and Kuipers F. The farnesoid X receptor. A molecular link between bile acid and lipid and glucose metabolism. Arterioscler. Thromb. Vasc. Biol. 25 (2005) C2020-C2031
9. Duran-Sandoval D., et al. Glucose regulates the expression of the farnesoid X receptor in liver. Diabetes 53 (2004) C890-C898
10. Goodwin B., et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 6 (2000) C517-C526
11. Kim M.S., Shigenaga J., Moser A., Feingold K., and Grunfeld C. Repression of farnesoid X receptor during the acute phase response. J. Biol. Chem. 278 (2003) C8988-C8995
12. Lambert G., Amar M.J.A., Guo G., Brewer Jr. H.B., Gonzalez F.J., and Sinal C.J. The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. J. Biol. Chem. 278 (2003) C2563-C2570
13. Lee Y.H., Saue R.B., and Gonzalez F.J. Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1alpha knockout mouse. Mol. Cell. Biol. 18 (1998) C3059-C3068
14. Ma K., Saha P.K., Chan L., and Moore D.D. Farnesoid X receptor is essential for normal glucose homeostasis. J. Clin. Invest. 116 (2006) C1102-C1109
15. Makishima M., et al. Identification of a nuclear receptor for bile acids. Science 284 (1999) C1362-C1365
16. Ott M.O., Rey-Campos J., Cereghini S., and Yaniv M. vHNF1 is expressed in epithelial cells of distinct embryonic origin during development and precedes HNF1 expression. Mech. Dev. 36 (1991) C47-C58
17. Parks D.J., et al. Bile acids: natural ligands for an orphan nuclear receptor. Science 284 (1999) C1365-C1368
18. Pontoglio M. Hepatocyte nuclear factor 1, a transcription factor at the crossroads of glucose homeostasis. J. Am. Soc. Nephrol. 11 Suppl 16 (2000) CS140-CS143
19. Pontoglio M., et al. Hepatocyte nuclear factor 1 inactivation results in hepaticdysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 84 (1996) C575-C585
20. Pontoglio M., Faust D.M., Doyen A., Yaniv M., and Weiss M.C. Hepatocyte nuclear factor 1alpha gene inactivation impairs chromatin remodeling and demethylation of the phenylalanine hydroxylase gene. Mol. Cell. Biol. 17 (1997) C4948-C4956
21. Rizzo G., et al. FXR promotes adipocyte differentiation and regulates adipose cell function in vivo. Pharmacology and experimental therapeutics. Mol. Pharmacol. 70 (2006) C1164-C1173
22. Ryffel G.U. Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. J. Mol. Endocrinol. 27 (2001) C11-C29
23. Shih D.Q., et al. Hepatocyte nuclear factor-1 is an essential regulator of bile acid and plasma cholesterol metabolism. Nat. Genet. 27 (2001) C375-C382
24. Sinal C.J., Tohkin M., Miyata M., Ward J.M., Lambert G., and Gonzalez F.J. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102 (2000) C731-C744
25. Urizar N.L., Dowhan D.H., and Moore D.D. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J. Biol. Chem. 275 (2000) C39313-C39317
26. Wang H., Chen J., Hollister K., Sowers L.C., and Forman B.M. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell 3 (1999) C543-C553
27. Watanabe M., et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Invest. 113 (2004) C1408-C1418
28. Yamataga K., et al. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 384 (1996) C455-C458
29. Zhang Y., Kast-Woelbern H.R., and Edwards P.A. Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation. J. Biol. Chem. 278 (2003) C104-C110
30. Zhou D., Clark P., Wang F., and Chen S. Identification of a promoter that controls aromatase expression in human breast cancer and adipose stromal cells. J. Biol. Chem. 271 (1996) C15194-C15202